Progyny, Inc. Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net
Progyny, Inc. (PGNY) reported Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net of $3.24 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherNoncurrentAssetsAndLiabilitiesNet · last filed 2026-08-07
- Progyny, Inc. increase (decrease) in other noncurrent assets and liabilities, net for the quarter ending 2026-06-30 was $829.00K, a 99.28% increase year-over-year.
- Progyny, Inc. increase (decrease) in other noncurrent assets and liabilities, net for the quarter ending 2026-03-31 was $2.41M, a 226.15% increase year-over-year.
- Progyny, Inc. increase (decrease) in other noncurrent assets and liabilities, net for the quarter ending 2025-12-31 was $9.35M.
- Progyny, Inc. increase (decrease) in other noncurrent assets and liabilities, net for the quarter ending 2025-09-30 was -$1.19M, a 412.57% decline year-over-year.
- Progyny, Inc. increase (decrease) in other noncurrent assets and liabilities, net for fiscal 2025 was $9.31M.
- Progyny, Inc. increase (decrease) in other noncurrent assets and liabilities, net for fiscal 2024 was -$425.00K.
- Progyny, Inc. increase (decrease) in other noncurrent assets and liabilities, net for fiscal 2023 was -$648.00K, a 160.00% decline from fiscal 2022.
- Progyny, Inc. increase (decrease) in other noncurrent assets and liabilities, net for fiscal 2022 was $1.08M, a 67.07% decline from fiscal 2021.
| Period end | Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net 3 month | Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net 6 month | Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net 9 month | Increase (Decrease) in Other Noncurrent Assets and Liabilities, Net 12 month |
|---|---|---|---|---|
| 2026-06-30 | $829.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $3.24M 10-Q · filed 2026-08-07 | $12.58M derived: sum of 3 quarters · filed 2026-08-07 | $11.39M derived: sum of 4 quarters · filed 2026-08-07 |
| 2026-03-31 | $2.41M 10-Q · filed 2026-05-08 | $11.75M derived: sum of 2 quarters · filed 2026-05-08 | $10.56M derived: sum of 3 quarters · filed 2026-05-08 | $10.97M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-12-31 | $9.35M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | $8.15M derived: sum of 2 quarters · filed 2026-02-27 | $8.57M derived: sum of 3 quarters · filed 2026-08-07 | $9.31M 10-K · filed 2026-02-27 |
| 2025-09-30 | -$1.19M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | -$778.00K derived: sum of 2 quarters · filed 2026-08-07 | -$40.00K 10-Q · filed 2025-11-07 | -$461.00K derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-06-30 | $416.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $1.15M 10-Q · filed 2026-08-07 | $733.00K derived: sum of 3 quarters · filed 2026-08-07 | $1.11M derived: sum of 4 quarters · filed 2026-08-07 |
| 2025-03-31 | $738.00K 10-Q · filed 2026-05-08 | $317.00K derived: sum of 2 quarters · filed 2026-05-08 | $699.00K derived: sum of 3 quarters · filed 2026-05-08 | $444.00K derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | -$421.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$39.00K derived: sum of 2 quarters · filed 2026-02-27 | -$294.00K derived: sum of 3 quarters · filed 2026-02-27 | -$425.00K 10-K · filed 2026-02-27 |
| 2024-09-30 | $382.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $127.00K derived: sum of 2 quarters · filed 2025-11-07 | -$4.00K 10-Q · filed 2025-11-07 | -$160.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-06-30 | -$255.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$386.00K 10-Q · filed 2025-08-08 | -$542.00K derived: sum of 3 quarters · filed 2026-02-27 | -$453.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2024-03-31 | -$131.00K 10-Q · filed 2025-05-09 | -$287.00K derived: sum of 2 quarters · filed 2026-02-27 | -$198.00K derived: sum of 3 quarters · filed 2026-02-27 | -$558.00K derived: sum of 4 quarters · filed 2026-02-27 |
| 2023-12-31 | -$156.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-27 | -$67.00K derived: sum of 2 quarters · filed 2026-02-27 | -$427.00K derived: sum of 3 quarters · filed 2026-02-27 | -$648.00K 10-K · filed 2026-02-27 |
| 2023-09-30 | $89.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | -$271.00K derived: sum of 2 quarters · filed 2024-11-12 | -$492.00K 10-Q · filed 2024-11-12 | -$622.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-06-30 | -$360.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-07 | -$581.00K 10-Q · filed 2024-08-07 | -$711.00K derived: sum of 3 quarters · filed 2025-03-03 | -$869.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2023-03-31 | -$221.00K 10-Q · filed 2024-05-10 | -$351.00K derived: sum of 2 quarters · filed 2025-03-03 | -$509.00K derived: sum of 3 quarters · filed 2025-03-03 | -$515.00K derived: sum of 4 quarters · filed 2025-03-03 |
| 2022-12-31 | -$130.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | -$288.00K derived: sum of 2 quarters · filed 2025-03-03 | -$294.00K derived: sum of 3 quarters · filed 2025-03-03 | $1.08M 10-K · filed 2025-03-03 |
| 2022-09-30 | -$158.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-08 | -$164.00K derived: sum of 2 quarters · filed 2023-11-08 | $1.21M 10-Q · filed 2023-11-08 | $3.50M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | -$6.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04 | $1.37M 10-Q · filed 2023-08-04 | $3.66M derived: sum of 3 quarters · filed 2024-02-29 | $4.67M derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $1.37M 10-Q · filed 2023-05-09 | $3.66M derived: sum of 2 quarters · filed 2024-02-29 | $4.67M derived: sum of 3 quarters · filed 2024-02-29 | $4.66M derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $2.29M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $3.30M derived: sum of 2 quarters · filed 2024-02-29 | $3.29M derived: sum of 3 quarters · filed 2024-02-29 | $3.28M 10-K · filed 2024-02-29 |
| 2021-09-30 | $1.01M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $999.00K derived: sum of 2 quarters · filed 2022-11-04 | $992.00K 10-Q · filed 2022-11-04 | $1.06M derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-06-30 | -$13.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | -$20.00K 10-Q · filed 2022-08-05 | $52.00K derived: sum of 3 quarters · filed 2023-03-01 | -$298.00K derived: sum of 4 quarters · filed 2023-03-01 |
| 2021-03-31 | -$7.00K 10-Q · filed 2022-05-06 | $65.00K derived: sum of 2 quarters · filed 2023-03-01 | -$285.00K derived: sum of 3 quarters · filed 2023-03-01 | |
| 2020-12-31 | $72.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01 | -$278.00K derived: sum of 2 quarters · filed 2023-03-01 | -$605.00K 10-K · filed 2023-03-01 | |
| 2020-09-30 | -$350.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | -$677.00K 10-Q · filed 2021-11-08 | ||
| 2020-06-30 | -$327.00K 10-Q · filed 2021-08-06 | |||
| 2019-12-31 | -$287.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $230.00K derived: sum of 2 quarters · filed 2022-03-01 | $380.00K 10-K · filed 2022-03-01 | |
| 2019-09-30 | $517.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-06 | $667.00K 10-Q · filed 2020-11-06 | ||
| 2019-06-30 | $150.00K 10-Q · filed 2020-08-07 | |||
| 2018-12-31 | -$100.00K 10-K · filed 2021-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| agilon health, inc. (AGL) | United States | $1.272B | -7.76 |
| VIEMED HEALTHCARE, INC. (VMD) | United States | $0.336B | 29.92 |
| Park Dental Partners, Inc. (PARK) | United States | $0.094B | |
| BioRestorative Therapies, Inc. (BRTX) | United States | $0.064B | |
| CRYO CELL INTERNATIONAL INC (CCEL) | United States | $0.033B | -11.02 |
| MANGOCEUTICALS, INC. (MGRX) | United States | $0.010B | -0.43 |
| Sotera Health Co (SHC) | United States | $5.271B | 30.96 |
| DAVITA INC. (DVA) | United States | $11.147B | 16.80 |